Islet T cells secreting IFN-γ in NOD mouse diabetes: Arrest by p277 peptide treatment

Journal of Autoimmunity

Volumn 11, Issue 1, 1998, Pages 73-81

  Ablamunits, Vitaly ^a   Elias, Dana ^a   Reshef, Tamara ^a   Cohen, Irun R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cytokines; NOD mouse; Peptide therapy

Indexed keywords

CD3 ANTIGEN; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 60; INTERLEUKIN 4; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; INSULITIS; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031913650     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0177     Document Type: Article

References (41)

1. Bach J.-F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15: 516-542
2. Roep B.O. 1996. T-cell responses to autoantigens in IDDM. The search for the Holy Grail. Diabetes 45: 1147-1156
3. Elias D., Reshef T., Birk O.S., van der Zee R., Walker M.D., Cohen I.R. 1991. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88: 3088-3091
4. Elias D., Cohen I.R. 1995. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 44: 1132-1138
5. Elias D., Cohen I.R. 1996. The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin. Diabetes 45: 1168-1172
6. Elias D., Meilin A, Ablamunits V., Birk O.S., Carmi P., Konen-Waisman S., Cohen I.R. 1997. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various β-cell antigens. Diabetes 46: 758-764
7. Sedgwick J.D., Holt RG. 1986. The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. J. Immunol. Methods 87: 37-44
8. Yang X., Hayglass K. 1993. A simple, sensitive, dual mAb based ELISA for murine gamma interferon determination: comparison with common bioassays. J. Immunoassay 14: 129-148
9. Harlow E., Lane D.P. 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
10. Gotoh M., Maki T., Kiyoizumi T., Satomi S., Monako A.P. 1985. An improved method for isolation of mouse pancreatic islets. Transplantation 40: 437-438
11. Leo O., Foo M., Sachs D.H., Samelson L.E., Bluestone J.A. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84: 1374-1378
12. Kelso A., Gough N.M. 1988. Coexpression of granulocyte-macrophage colony-stimulating factor, γ interferon, and interleukins 3 and 4 is random in murine alloreactive T-lymphocyte clones. Proc. Natl. Acad. Sci. USA 85: 9189-9193
13. Harada M., Makino S. 1984. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27: 604-606
14. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. 1980. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 29: 1-13
15. O'Reilly L.A., Hutchins PR., Crocker PR., Simpson E., Lund T., Kioussis D., Takei F., Baird J., Cooke A 1991. Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur. J. Immunol. 21: 1171-1180
16. Rabinovitch A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes 43: 613-621
17. Pukel C., Baquerizo H., Rabinovitch A. 1988. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-γ, tumour necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37: 133-136
18. Campbell I.L., Iscaro A., Harrison L.C. 1988. IFN-γ and tumour necrosis factor-a. Cytotoxicity to murine islets of Langerhans. J. Immunol. 141: 2325-2329
19. Rabinovitch A., Sumoski W., Rajotte R.V., Warnock G.L. 1990. Cytotoxic effects of cytokine on human pancreatic islet cells in monolayer culture. J. Clin. Endrocrinol. Metab. 71: 152-156
20. Prieto J., Kaaya E.E., Junti-Berggren L., Berggren P-O., Sandler S., Biberfeld P., Patarroyo M. 1992. Induction of intracellular adhesion molecule-1 (CD54) on isolated mouse pancreatic β cells by inflammatory cytokines. Clin. Immunol. Immunopathol. 65: 247-253
21. Campbell I.L., Wong G.H.W., Schrader J.W., Harrison L.C. 1985. Interferon-γ enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells. Diabetes 34: 1205-1209
22. Wright J.R., Lacy P.E., Unanue E.R., Muszynski C., Hauptfeld V. 1986. Interferon-mediated induction of Ia antigen expression on isolated murine whole islets and dispersed islet cells. Diabetes 35: 1174-1177
23. Paul W., Seder R.A. 1994. Lymphocyte responses and cytokines. Cell 76: 241-251
24. Sarvetnick N., Shizuru J., Liggit D., Martin L., McIntyre B., Gregory A., Parslow T., Stewart T. 1990. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature 346: 844-847
25. Gu D., Molony L., Krahl T., Sarvetnick N. 1995. Treatment of IFN-γ transgenic mice with anti-IFN-γ reveals the remodeling capacity of the adult pancreas. Diabetes 44: 1161-1164
26. Debray-Sachs M., Carnaud C., Boitard C., Cohen H., Gresser I., Bedossa P., Bach J.-F. 1991. Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ. J. Autoimmun. 4: 237-248
27. Herold K.C., Vezys V., Sun Q., Viktoria D., Seung E., Reiner S., Brown D.R. 1996. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J. Immunol 156: 3521-3527
28. Hultgren B., Huang X., Dybdal N., Stewart T.A. 1996. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45: 812-817
29. Sato J., Seino H., Abo T., Tanaka S.-I., Shintani S., Ohta S., Sawai T., Nobunga T., Oteki T., Kumagai K., Toyota T. 1989. Recombinant human tumor necrosis factor-α suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84: 1345-1348
30. Jacob C.O., Aiso S., Schreiber R.D., McDevitt H.O. 1992. Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development. Int. Immunol. 4: 611-614
31. Higuchi Y., Herrera P., Muniesa P., Huarte J., Belin D., Ohashi P., Aichele P., Orchi L., Vassalli J.D., Vassalli P. 1992. Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176: 1719-1731
32. Rapoport M.J., Jaramillo A., Zipris D., Lazarus A.H., Serreze D.V., Leiter E.H., Cyopick P., Danska J.S., Delovitch T.L. 1993. IL-4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in NOD mice. J. Exp. Med. 178: 87-99
33. Shehadeh N.N., LaRosa F., Lafferty K.J. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6: 291-300
34. Hancock W.W., Polanski M., Zhang J., Blogg N., Weiner H.L. 1995. Suppression of insulitis in NOD mice by oral insulin administration is associated with selective expression of IL-4,IL-10, TGF-β and prostaglandin-E. Am. J. Pathol. 147: 1193-1199
35. g7. Int. Immunol. 9: 43-51
36. Weiner H.L., Friedman A., Miller A., Khoury S.J., al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R.B., Trentham D.E., Hafler D.A. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune disease by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809-837
37. Snapper C.M., Mond J.J. 1993. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14: 15-17
38. Birk O.S., Elias D., Weiss A.S., Rosen A., van-der Zee R., Walker M.D., Cohen I.R. 1996. NOD mouse diabetes: the ubiquitous mouse hsp60 is a β-cell target antigen of autoimmune T cells. J. Autoimmun. 9: 159-166
39. Sloan-Lancaster J., Allen P.M. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14: 1-27
40. Bonner-Weir S., Baxter L.A., Schuppin G.T., Smith F.E. 1993. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42: 1715-1720
41. Cohen I.R. 1995. Treatment of autoimmune disease: to activate or to deactivate? Chem. Immunol. 60: 150-160